Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV001095281 | SCV000468680 | benign | Charcot-Marie-Tooth disease type 2D | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000372862 | SCV000468681 | benign | Distal spinal muscular atrophy | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000261919 | SCV000468682 | benign | Neuronopathy, distal hereditary motor, type 5A | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Gene |
RCV000429266 | SCV000513113 | benign | not specified | 2015-07-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000473112 | SCV000561331 | benign | Charcot-Marie-Tooth disease type 2 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000514172 | SCV000610769 | likely benign | not provided | 2017-04-05 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000514172 | SCV001143985 | benign | not provided | 2019-03-11 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001173309 | SCV001336393 | benign | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV000514172 | SCV002047856 | likely benign | not provided | 2022-04-06 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000514172 | SCV005226663 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Ce |
RCV000514172 | SCV005330284 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | GARS1: BP4, BS1, BS2 |
Mayo Clinic Laboratories, |
RCV000514172 | SCV000802508 | benign | not provided | 2017-10-31 | no assertion criteria provided | clinical testing |